X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | MRK | Litchfield Caroline | EVP, CFO | S - Sale+OE | $125.50 | -38,291 | 50,908 | -43% | -$4,805,521 | |||||
| DM | 2024-02-13 | MRK | Davis Robert M | COB, CEO, Pres | S - Sale+OE | $125.69 | -235,021 | 348,327 | -40% | -$29,538,998 | |||||
2024-02-13 | MRK | Romanelli Joseph | Pres, Human Health Int?l | S - Sale | $124.89 | -1,000 | 19,569 | -5% | -$124,888 | ||||||
| D | 2024-02-09 | MRK | Li Dean Y | EVP, Pres, MRL | S - Sale+OE | $125.50 | -14,702 | 46,242 | -24% | -$1,845,083 | |||||
2024-02-07 | MRK | Williams David Michael | EVP,Chief Info, Digital Office | S - Sale | $127.57 | -1,451 | 19,812 | -7% | -$185,108 | ||||||
| D | 2024-02-02 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale+OE | $127.18 | -18,959 | 23,327 | -45% | -$2,411,111 | |||||
| D | 2024-02-02 | MRK | Mizell Steven | EVP, CHRO | S - Sale+OE | $126.65 | -50,694 | 23,619 | -68% | -$6,420,349 | |||||
| D | 2024-02-02 | MRK | Zachary Jennifer | EVP, GC | S - Sale+OE | $126.97 | -49,499 | 29,058 | -63% | -$6,284,779 | |||||
2023-11-09 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale | $102.38 | -2,081 | 18,191 | -10% | -$213,061 | ||||||
2023-11-08 | MRK | Deluca Richard R. | EVP, Pres, Merck Animal Heallt | S - Sale | $105.03 | -43,823 | 112,987 | -28% | -$4,602,668 | ||||||
2023-08-14 | MRK | Mizell Steven | EVP, CHRO | S - Sale | $109.01 | -4,250 | 22,935 | -16% | -$463,293 | ||||||
2023-08-03 | MRK | Mizell Steven | EVP, CHRO | S - Sale | $105.49 | -4,500 | 27,185 | -14% | -$474,701 | ||||||
2023-08-02 | MRK | Romanelli Joseph | Pres, Human Health Int?l | S - Sale | $107.37 | -89 | 20,569 | 0% | -$9,556 | ||||||
| M | 2022-12-02 | MRK | Romanelli Joseph | Pres, Human Health Int?l | P - Purchase | $108.40 | +409 | 20,658 | +2% | +$44,336 | |||||
2023-03-24 | MRK | Romanelli Joseph | Pres, Human Health Int?l | S - Sale | $104.65 | -35 | 20,658 | 0% | -$3,663 | ||||||
| D | 2023-05-03 | MRK | Mizell Steven | EVP, CHRO | S - Sale+OE | $119.01 | -53,400 | 31,685 | -63% | -$6,355,056 | |||||
2023-05-04 | MRK | Zachary Jennifer | EVP, GC | S - Sale | $117.59 | -19,141 | 35,128 | -35% | -$2,250,834 | ||||||
| D | 2023-05-04 | MRK | Karachun Rita A | SVP Fince-Global Controller | S - Sale+OE | $117.53 | -15,875 | 45,710 | -26% | -$1,865,843 | |||||
| D | 2023-05-02 | MRK | Williams David Michael | EVP,Chief Info, Digital Office | S - Sale+OE | $116.82 | -7,509 | 11,059 | -40% | -$877,222 | |||||
| DM | 2023-04-28 | MRK | Deluca Richard R. | EVP, Pres, Merck Animal Heallt | S - Sale+OE | $115.55 | -141,599 | 155,699 | -48% | -$16,361,593 | |||||
| D | 2023-04-28 | MRK | Davis Robert M | COB, CEO, Pres | S - Sale+OE | $114.93 | -143,329 | 271,817 | -35% | -$16,472,845 | |||||
| D | 2023-04-13 | MRK | Chattopadhyay Sanat | Exe V-P, Pres MMD | S - Sale+OE | $115.07 | -134,055 | 130,476 | -51% | -$15,425,068 | |||||
2023-02-15 | MRK | Romanelli Joseph | Pres, Human Health Int?l | S - Sale | $108.22 | -5,000 | 20,284 | -20% | -$541,101 | ||||||
2023-02-13 | MRK | Mizell Steven | EVP, CHRO | S - Sale | $109.10 | -1,815 | 33,085 | -5% | -$198,017 | ||||||
2023-02-09 | MRK | Mizell Steven | EVP, CHRO | S - Sale | $107.00 | -5,000 | 34,900 | -13% | -$535,007 | ||||||
2023-02-06 | MRK | Mizell Steven | EVP, CHRO | S - Sale | $104.26 | -4,436 | 39,900 | -10% | -$462,473 | ||||||
| D | 2023-02-03 | MRK | Zachary Jennifer | EVP, GC | S - Sale+OE | $103.17 | -75,436 | 53,920 | -58% | -$7,782,762 | |||||
| D | 2023-01-09 | MRK | Chattopadhyay Sanat | Exe V-P, Pres MMD | S - Sale+OE | $112.29 | -83,994 | 112,981 | -43% | -$9,431,915 | |||||
| DM | 2022-11-08 | MRK | Mizell Steven | EVP, CHRO | S - Sale+OE | $101.18 | -35,000 | 32,144 | -52% | -$3,541,278 | |||||
2022-11-09 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale | $103.21 | -1,795 | 16,731 | -10% | -$185,262 | ||||||
| D | 2022-11-09 | MRK | Davis Robert M | CEO, Pres | S - Sale+OE | $102.44 | -167,613 | 247,593 | -40% | -$17,169,840 | |||||
| D | 2022-11-07 | MRK | Frazier Kenneth C | Exec Chair | S - Sale+OE | $99.55 | -235,769 | 705,134 | -25% | -$23,471,433 | |||||
| D | 2022-11-07 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale+OE | $99.47 | -45,561 | 18,526 | -71% | -$4,531,980 | |||||
| DM | 2022-11-03 | MRK | Frazier Kenneth C | Exec Chair | S - Sale+OE | $98.66 | -470,000 | 705,134 | -40% | -$46,372,118 | |||||
| DM | 2022-11-01 | MRK | Frazier Kenneth C | Exec Chair | S - Sale+OE | $99.86 | -600,000 | 705,134 | -46% | -$59,914,706 | |||||
| D | 2022-10-28 | MRK | Chattopadhyay Sanat | Exe V-P, Pres MMD | S - Sale+OE | $100.10 | -100,292 | 112,981 | -47% | -$10,039,380 | |||||
| D | 2022-10-28 | MRK | Deluca Richard R. | EVP, Pres, Merck Animal Heallt | S - Sale+OE | $100.26 | -164,557 | 138,170 | -54% | -$16,499,094 | |||||
| DM | 2022-10-28 | MRK | Frazier Kenneth C | Exec Chair | S - Sale+OE | $100.44 | -867,084 | 710,764 | -55% | -$87,090,363 | |||||
| D | 2022-10-28 | MRK | Karachun Rita A | SVP Fince-Global Controller | S - Sale+OE | $100.34 | -31,997 | 41,103 | -44% | -$3,210,685 | |||||
| D | 2022-10-28 | MRK | Mizell Steven | EVP, CHRO | S - Sale+OE | $99.63 | -25,000 | 32,144 | -44% | -$2,490,720 | |||||
| D | 2022-10-28 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale+OE | $100.21 | -3,633 | 11,344 | -24% | -$364,065 | |||||
| D | 2022-10-28 | MRK | Zachary Jennifer | EVP, GC | S - Sale+OE | $99.38 | -165,255 | 38,040 | -81% | -$16,422,893 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |